Plain-English translation of NCT07286175 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bipolar Disorder research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a medication called — given as a self-administered injection under the skin — to see if it can help prevent bipolar disorder symptoms from getting worse when added to your regular treatment. About 400 adults with bipolar disorder will participate. Half will receive the new medication while the other half will receive a placebo (fake injection), and everyone will continue their standard bipolar disorder care.
Even with current treatments, many people with bipolar disorder still experience relapses—times when their symptoms get worse. Researchers are looking for ways to make existing treatments more effective by adding this medication to help people stay stable longer.
You likely qualify if…
You likely don't qualify if…
You'll start with a 1-month screening period where the study team makes sure you're a good fit. Then you'll enter the main treatment phase lasting at least 6 months, during which you'll inject the medication (or placebo) under your skin, keep study diaries on paper or electronically, and attend regular visits to track how you're doing. Finally, there's a 2-month follow-up period. Throughout, you'll continue taking your regular bipolar disorder medications as prescribed.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
United States